Event Details
Agenda
5:30 – 5:35 PM
Introduction to speakers by Dr. Natalie Rickers (Director, Research and Strategy, Cholangiocarcinoma Foundation Australia)
5:35 – 5:50 PM
Genetic Testing and MoST/CaSP Cholangiocarcinoma-Specific Data
Presented by Professor David Thomas
5:50 – 6:05 PM
Standardisation of Australian Treatment Pathways
Presented by Professor John Zalcberg
6:05 – 6:20 PM
Beyond Cis-Gem Durvalumab in Advanced BTC
Presented by Professor Juan Valle
6:20 – 6:30 PM
Q&A Session
About the Speakers
Professor David Thomas
Founder and Chief Strategy Officer, Omico
Professor Thomas is a leading authority in genomic oncology, integrating genomic profiling into clinical care to enable personalized treatment strategies. His pioneering work has transformed the management of rare and aggressive cancers, including cholangiocarcinoma.
Professor John Zalcberg, AO, MBBS, PhD, FRACP, FRACMA, FAHMS
Head of Cancer Research Program, School of Public Health and Preventive Medicine, Monash University
Professor Zalcberg is an internationally recognized oncologist and researcher. As a co-founder of the Australasian Gastrointestinal Trials Group (AGITG), his contributions to gastrointestinal cancer research and policy have shaped cancer care in Australia. He is a recipient of the Officer of the Order of Australia (AO) for his services to oncology.
Professor Juan Valle, MB ChB, MSc, FRCP
Chief Medical Officer, Cholangiocarcinoma Foundation USA (Special Guest)
Professor Valle is a globally respected expert in hepatobiliary cancers. As the first Chief Medical Officer of the Cholangiocarcinoma Foundation USA, he leads initiatives to advance research and care for this challenging cancer type. His groundbreaking work has significantly impacted the understanding and treatment of biliary tract cancers globally.
About the Organisations
This webinar is an opportunity to connect with global experts, gain insights into cutting-edge approaches, and contribute to shaping the future of cholangiocarcinoma care in Australia.
About Omico
https://www.omico.com.au/
Omico is a national, not-for-profit organisation pioneering the integration of genomic profiling into cancer care. By leveraging precision oncology, Omico connects patients with personalised treatment options and innovative clinical trials, accelerating breakthroughs in cancer management across Australia.
About Cholangiocarcinoma Foundation Australia
www.cholangio.org
The Cholangiocarcinoma Foundation Australia is dedicated to transforming the landscape for bile duct cancer and bile-related diseases. Through research, advocacy, and education, we address the critical challenges posed by cholangiocarcinoma, focusing on prevention, early detection, and empowering patients to understand and respond effectively.
We look forward to welcoming you!
Kind regards,
Steve
